NCT07311811

A Study to Evaluate the Pharmacokinetics and Safety of IN-M00007 and IN-R00007 in Healthy Adult Volunteers

An Open Label, Randomized, 2-sequence, 2-period, Fasting, Single Oral Dose, Crossover Study to Evaluate the Bioequivalence and Safety of 'IN-M00007' and 'IN-R00007' in Healthy Adult Volunteers

• Status: Not Yet Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: HK inno.N Corporation · Industry
• Sex: All
• Age: 19 Years – 59 Years
• Healthy volunteers: Accepted

Summary

This study aims to evaluate the Pharmacokinetic (PK) characteristics and safety after a single oral dose administration of IN-M00007 and IN-R00007 in healthy adult volunteers

Detailed description

An open label, randomized, single oral dose, crossover study

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DRUG	IN-R00007	Single dose
DRUG	IN-M00007	Single dose

Timeline

• Start date: 2026-01-01
• Primary completion: 2026-03-01
• Completion: 2026-04-01
• First posted: 2025-12-31
• Last updated: 2025-12-31

Locations

1 site across 1 country: South Korea